Grants per year
Personal profile
Research Interests
My primary research interest is the induction of transplant tolerance; this applies to the prevention and treatment of a/cGVHD in hematopoietic stem cell transplantation and prevention and treatment of rejection in solid organ transplantation.
Developing new, non-toxic approaches to the induction of tolerance in the allogeneic transplant setting.
Hematopoietic stem cell transplantation in pediatric patients.
Certifications and Licenses
| Pediatrics | |
| Pediatric Hematology-Oncology |
Training Experience
| 2002 | Residency, Children's Hospital of Orange County |
| 2006 | Fellowship, Northwestern University, McGaw Medical Center (Children’s Memorial Hospital) |
| 2007 | Fellowship, Northwestern University, McGaw Medical Center (Children’s Memorial Hospital) |
Education/Academic qualification
MD, Chicago Medical School
… → 1998
Research interests
- Apoptosis
- Immune Regulation
- Stem Cells
- Transplantation
Fingerprint Dive into the research topics where Jennifer Schneiderman is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 10 Similar Profiles
Photopheresis
Medicine & Life Sciences
Transplants
Medicine & Life Sciences
Pediatrics
Medicine & Life Sciences
Stem Cells
Medicine & Life Sciences
Blood Component Removal
Medicine & Life Sciences
Hematopoietic Stem Cell Transplantation
Medicine & Life Sciences
Hematopoietic Stem Cells
Medicine & Life Sciences
Graft vs Host Disease
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Grants 2016 2018
- 2 Finished
FY2017 SMCRI Internal Grant Award/Visionary Award: Safety and Efficacy of ECP Treated Donor Cells in Prevention of Allograft Rejection and Xenogenic GVHD
Mathew, J., Schneiderman, J. & Zhang, Z. J.
Ann & Robert H. Lurie Children's Hospital of Chicago
6/1/17 → 11/30/18
Project: Research project
Allografts
Tissue Donors
Safety
Transplants
Living Donors
Extracorporeal Photopheresis (ECP) as a Novel Strategy for Transplant Tolerance Induction
Levitsky, J. & Schneiderman, J.
Northwestern Memorial Hospital
1/1/16 → 12/31/17
Project: Research project
Photopheresis
Transplants
Organ Transplantation
Immunosuppression
Cutaneous T-Cell Lymphoma
Research Output 2004 2019
4
Citations
(Scopus)
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice - Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
Padmanabhan, A., Connelly-Smith, L., Aqui, N., Balogun, R. A., Klingel, R., Meyer, E., Pham, H. P., Schneiderman, J., Witt, V., Wu, Y., Zantek, N. D., Dunbar, N. M. & Schwartz, G. E. J., Jun 1 2019, In : Journal of clinical apheresis. 34, 3, p. 171-354 184 p.Research output: Contribution to journal › Article
Blood Component Removal
Evidence-Based Practice
Therapeutic Uses
Guidelines
Therapeutics
5
Citations
(Scopus)
American council on ECP (ACE): Why now?
Edelson, R., Wu, Y. & Schneiderman, J., Aug 1 2018, In : Journal of Clinical Apheresis. 33, 4, p. 464-468 5 p.Research output: Contribution to journal › Article
Photopheresis
Methoxsalen
Cutaneous T-Cell Lymphoma
Neoplasms
Transplants
Fecal calprotectin and serum albumin as markers of gastrointestinal graft versus host disease
Broglie, L., Rademaker, A. W., Galvin, J., Ray, A., Tse, W. T., Duerst, R. E., Schneiderman, J., Kletzel, M. & Chaudhury, S., Sep 1 2018, In : Hematology/ Oncology and Stem Cell Therapy. 11, 3, p. 169-174 6 p.Research output: Contribution to journal › Article
Leukocyte L1 Antigen Complex
Graft vs Host Disease
Serum Albumin
Albumins
Hematopoietic Stem Cell Transplantation
High-dose chemotherapy and autologous hematopoietic stem-cell rescue for treatment of relapsed and refractory Wilms tumor: Re-evaluating outcomes
Rossoff, J., Tse, W. T., Duerst, R. E., Schneiderman, J., Morgan, E. R., Kletzel, M. & Chaudhury, S., Aug 18 2018, In : Pediatric Hematology and Oncology. 35, 5-6, p. 316-321 6 p.Research output: Contribution to journal › Article
Wilms Tumor
Hematopoietic Stem Cells
Salvage Therapy
Drug Therapy
Disease-Free Survival
5
Citations
(Scopus)
Late Effects in Pediatric High-risk Neuroblastoma Survivors after Intensive Induction Chemotherapy Followed by Myeloablative Consolidation Chemotherapy and Triple Autologous Stem Cell Transplants
Armstrong, A. E., Danner-Koptik, K., Golden, S., Schneiderman, J., Kletzel, M., Reichek, J. & Gosiengfiao, Y., Jan 1 2018, In : Journal of pediatric hematology/oncology. 40, 1, p. 31-35 5 p.Research output: Contribution to journal › Article
Consolidation Chemotherapy
Induction Chemotherapy
Neuroblastoma
Survivors
Stem Cells